<DOC>
	<DOC>NCT02187575</DOC>
	<brief_summary>Study to investigate the bioequivalence between 10 mg tablets (test drug) and 10 mg capsules (reference drug) of meloxicam (UHAC 62 XX) after 7-day administration.</brief_summary>
	<brief_title>Bioequivalence Study of UHAC62XX Tablets Compared With Capsules in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Age &gt;= 20 and &lt;= 35 years Weight: Body Mass Index &gt;= 18.5 and &lt; 25 Subjects who are judged by the investigator to be appropriate as the subjects of the study based on results of screening test Subjects who volunteer to participate and are able to fully understand and agree with this study by written informed consent History of gastrointestinal ulcer or surgery of gastrointestinal tract (except appendectomy) History of hypersensitivity to UHAC 62 XX and/or salicylate (aspirin etc.) and/or Nonsteroidal antiinflammatory drugs (NSAIDs) History of aspirin induced asthma (bronchial asthma induced by NSAIDs) History of bleeding tendency History of alcohol or drug abuse Participation to another trial with an investigational drug within 4 months prior to the trial Whole blood donation more than 400 ml within 3 months prior to the trial Whole blood donation more than 100 ml within 1 month prior to the trial Donation of constituent of blood of more than 400 ml within 1 month prior to the trial Any medication which might influence the results of the trial within 10 days prior to the trial Excessive physical activities within 7 days prior to the trial Alcohol drinking within 3 days prior to the trial History of orthostatic hypotension, fainting spells or blackouts Other than above, those who are judged by the investigator to be inappropriate as the subjects of the study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>